Seeking Alpha

Shares of NeoProbe (NEOP) jump in post-trading after the FDA agrees to review its new-drug...

Shares of NeoProbe (NEOP) jump in post-trading after the FDA agrees to review its new-drug application for its cancer-detection agent Lymphoseek. Shares +16% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)